ProfileGDS4718 / 205263_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 99% 99% 95% 99% 99% 97% 97% 99% 99% 99% 99% 99% 98% 96% 98% 99% 98% 98% 96% 98% 99% 99% 99% 99% 99% 98% 99% 97% 99% 98% 98% 95% 99% 99% 96% 93% 98% 99% 99% 91% 99% 98% 97% 94% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]12.325299
GSM549102patient 115, normal, homogenized [OPG study]12.275999
GSM549104patient 119, normal, homogenized [OPG study]10.383595
GSM549108patient 138, normal, homogenized [OPG study]12.151599
GSM549119patient 077, normal, homogenized [OPG study]12.16499
GSM549133patient 032, cancer, homogenized [OPG study]10.9797
GSM549139patient 042, cancer, homogenized [OPG study]10.91397
GSM549099patient 107, normal, homogenized [OPG study]12.015199
GSM549109patient 139, normal, homogenized [OPG study]12.370899
GSM549110patient 046, normal, homogenized [OPG study]12.147399
GSM549114patient 063, normal, homogenized [OPG study]12.281499
GSM549122patient 082, normal, homogenized [OPG study]12.113699
GSM549134patient 033, cancer, homogenized [OPG study]11.509398
GSM549136patient 036, cancer, homogenized [OPG study]10.476896
GSM549140patient 044, cancer, homogenized [OPG study]11.137698
GSM549111patient 047, normal, homogenized [OPG study]12.454799
GSM549113patient 057, normal, homogenized [OPG study]12.038598
GSM549132patient 031, cancer, homogenized [OPG study]11.102998
GSM549137patient 038, cancer, homogenized [OPG study]10.547296
GSM549142patient 047, cancer, homogenized [OPG study]10.677998
GSM549100patient 110, normal, homogenized [OPG study]12.210899
GSM549107patient 135, normal, homogenized [OPG study]12.352299
GSM549115patient 068, normal, homogenized [OPG study]12.279299
GSM549116patient 072, normal, homogenized [OPG study]12.242399
GSM549120patient 078, normal, homogenized [OPG study]12.407199
GSM549131patient 030, cancer, homogenized [OPG study]11.289398
GSM549118patient 074, normal, homogenized [OPG study]12.37899
GSM549129patient 027, cancer, homogenized [OPG study]10.609297
GSM549123patient 088, normal, homogenized [OPG study]12.332199
GSM549124patient 006, cancer, homogenized [OPG study]11.172198
GSM549126patient 015, cancer, homogenized [OPG study]11.320698
GSM549128patient 025, cancer, homogenized [OPG study]10.266695
GSM549103patient 117, normal, homogenized [OPG study]12.482899
GSM549117patient 073, normal, homogenized [OPG study]12.670199
GSM549138patient 041, cancer, homogenized [OPG study]10.47596
GSM549141patient 045, cancer, homogenized [OPG study]9.8935893
GSM549130patient 028, cancer, homogenized [OPG study]11.367798
GSM549101patient 111, normal, homogenized [OPG study]12.297699
GSM549105patient 128, normal, homogenized [OPG study]12.04699
GSM549106patient 134, normal, homogenized [OPG study]9.5926291
GSM549112patient 048, normal, homogenized [OPG study]12.12199
GSM549125patient 011, cancer, homogenized [OPG study]11.178798
GSM549127patient 024, cancer, homogenized [OPG study]10.916697
GSM549135patient 035, cancer, homogenized [OPG study]10.070594